Tissue microarrays for high-throughput molecular profiling of tumor specimens
Juha Kononen(Docrates Cancer Center), Olli-P. Kallionimeni(National Institutes of Health), Guido Sauter(Universität Hamburg), J. Torhorst(University of Basel), Maarit Bärlund(Tampere University Hospital), Lukas Bubendorf(University of Basel), Michael J. Mihatsch(GTx (United States)), Anne Kallionimeni(National Institutes of Health), Peter Schraml(University Hospital of Zurich), Stephen B. Leighton
Cited by 4,134
Related Papers
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection
|American Journal of Transplantation|2003|1.1k
Quantitative comparison of DNA methylation assays for biomarker development and clinical applications
|Nature Biotechnology|2016|347
FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair
|Nature Genetics|2012|244
Prevalence of KIT Expression in Human Tumors
|Journal of Clinical Oncology|2004|222